<aside> <img src="/icons/apple_blue.svg" alt="/icons/apple_blue.svg" width="40px" /> Describe your product
Our product is derived from Bacillus spp. used to mitigate AHPND in shrimp aquaculture is typically a probiotic formulation. This product contains live, beneficial Bacillus bacteria known for their ability to enhance shrimp immunity and inhibit harmful pathogens like Vibrio parahaemolyticus, which causes AHPND.
<aside> <img src="/icons/brain_blue.svg" alt="/icons/brain_blue.svg" width="40px" /> Describe your target customers
<aside> <img src="/icons/emoji-disappointed_pink.svg" alt="/icons/emoji-disappointed_pink.svg" width="40px" /> What pain points are you trying to solve?
We aim to address the critical challenge of bacterial diseases in shrimp aquaculture, particularly those caused by Vibrio clade bacteria, which are responsible for severe diseases like AHPND (Acute Hepatopancreatic Necrosis Disease).
</aside>
<aside> <img src="/icons/bullseye_green.svg" alt="/icons/bullseye_green.svg" width="40px" /> What you want to achieve by March 2025
Our 6-month goal is to validate the efficacy of selected Bacillus species in protecting Litopenaeus vannamei (Pacific white shrimp) from AHPND.
This involves conducting lab and field trials, optimizing treatment protocols, and collecting data on shrimp health, survival rates, and disease resistance.
By the end of this period, the aim is to have a clear understanding of how to apply Bacillus spp. in aquaculture settings for disease prevention.
</aside>
<aside> <img src="/icons/bell-notification_pink.svg" alt="/icons/bell-notification_pink.svg" width="40px" /> Describe the kinds of help you need the most (funding, expertise, technology, access, etc).